New implant could help SMA patients who Can't get spinal injections
Disease control
Recruiting now
This trial tests a new implantable device called ThecaFlex DRx in 90 people with spinal muscular atrophy (SMA) who cannot receive standard spinal injections due to spine problems or other risks. The device is placed under the skin and delivers the medication nusinersen directly i…
Phase: NA • Sponsor: Alcyone Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC